News
For female patients with multiple sclerosis (MS), transcutaneous posterior tibial nerve stimulation (TPTNS) and repetitive ...
UroGen Pharma (NASDAQ:URGN) announced on Wednesday that the U.S. FDA has scheduled an Oncologic Drugs Advisory Committee ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback